Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harding

Showing results (891-900 of 946) with videos related to

Pageof 95
Sort By:
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Nature Communications|August 16, 2023
Genome-wide association studies reveal novel loci associated with pyrethroid and organophosphate resistance in Anopheles gambiae and Anopheles coluzziiEric R Lucas, Sanjay C Nagi, Alexander Egyir-Yawson, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Future Oncology (London, England)|August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancerJames J Harding, Jia Fan, Do-Youn Oh, et al.
Cancer|November 15, 2018
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutationsRaja R Narayan, John M Creasy, Debra A Goldman, et al.
The Lancet. Oncology|December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialThomas Yau, Joong-Won Park, Richard S Finn, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 95

Showing results (891-900 of 946) with videos related to

Sort By:
Pageof 95
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Nature Communications|August 16, 2023
Genome-wide association studies reveal novel loci associated with pyrethroid and organophosphate resistance in Anopheles gambiae and Anopheles coluzziiEric R Lucas, Sanjay C Nagi, Alexander Egyir-Yawson, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Future Oncology (London, England)|August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancerJames J Harding, Jia Fan, Do-Youn Oh, et al.
Cancer|November 15, 2018
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutationsRaja R Narayan, John M Creasy, Debra A Goldman, et al.
The Lancet. Oncology|December 16, 2021
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialThomas Yau, Joong-Won Park, Richard S Finn, et al.
Cancer|August 5, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomesParisa Momtaz, Catherine A O'Connor, Joanne F Chou, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 95